Delivery Order SPE2DB20D3104-SPE2DB24FV7T4

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of M-M-R II (Measles-Mumps-Rubella) vaccine vials to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,024.76 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA), a Department of Defense (DoD) agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,958.67 and is a firm fixed-price delivery order that runs through June 21, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of M-M-R II vaccine vials to the government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $1,024.76. The contract has a completion date of July 5, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical that runs through December 31, 2025. This IDC serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The contract has a firm fixed-price of $1,537.14 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA). The $1,661.67 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 24, 2025 with an ultimate completion date of February 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,038.31 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp also holds a significant Indefinite...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract has a firm fixed price of $2,175.98 and a completion date of June 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $4,408.42, was awarded on July 8, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a completion date of July 9, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The award has a firm fixed price of $3,156.27 and an ultimate completion date of August 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the government to...
This federal contract award, valued at $5,787.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor. The contract is for the delivery of M-M-R II vaccine vials, a vaccine used to prevent measles, mumps, and rubella. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 30, 2024. No set-aside designation was used for this award. Amerisourcebergen...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV7T4
    Delivery Order

This federal contract award is for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA). The contract, valued at $1,024.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024 with a completion date of June 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/24/24, 9:11 AM